Name: Himalayan Institute Neti Pot Salt,24 Oz (1.5 lbs),Each,028106-3
Brand: HIMALAYAN INSTITUTE
SKU: 44029-233254
Price: 21.35 USD
Availability: InStock

Himalayan Institute Neti Pot Salt,24 Oz (1.5 lbs),Each,028106-3 - 44029-233254

By HIMALAYAN INSTITUTE

$21.35

(781 Reviews)

Model

44029-233254

Store

health products for you
Extensive Range Of Clinically Proven Products. Safe And Secure. Crafted For Patient Safety. 10% Reward $ - Sitewide. Types: Wound Care, Ostomy, Incontinence, Urologicals, Respiratory, Women's Health, Patient Care, Mobility, Daily Aids, Special Needs. Healthcare

Manufacturer

HIMALAYAN INSTITUTE

Detail

Himalayan Institute Neti Pot Salt is the purest available, so that impurities in the salt do not irritate gentle nasal passages. It is 99.99 percent pure non-iodized salt. No additives or anti-caking agents. 10oz Neti salt bag is biodegradable and 24oz Neti salt bag is natural kraft bag.>

Category

Respiratory

Medical News Bulletin - According to 2020 statistics, Canadians have steadily reduced their intake of beef and pork in recent years. Some avoid eating meat for ethical reasons, while others are worried about negative health effects.1 Meat is a great source of protein, which is an important building block for the body.2 However, meat can also have high amounts […] The post Plant-Based Meat Alternatives For a Healthier Heart appeared first on Medical News Bulletin . ...

>Read More

Medical News Bulletin - Navigating the tumultuous waters of finals in college is a feat that every student encounters. Its a period characterized by sleepless nights, endless studying, and the pressure to excel in every assignment and exam. As deadlines loom and homework piles up, the accompanying stress can feel overwhelming. Amidst the chaos, there exists a powerful yet […] The post Harnessing the Power of Breathwork for Stress Reduction During Finals appeared first on Medical News Bulletin . ...

>Read More

Medical News Bulletin - In dermatology, the skin is our canvas, our subject of admiration, and a testament to our expertise. As the seasons shift, so does our approach to treating and maintaining this vast organ. Winter poses unique challenges because it can swiftly convert supple, hydrated skin into a dry, flaky, and often irritated expanse. Thus, prepping our […] The post Hear That Winter Whisper It’s Time For Dermatological Dialogues on Cold Weather Care appeared first on Medical News Bulletin . ...

>Read More

Medical News Bulletin - The use of AI and advanced analyzer technology in particle analysis has transformed operations by providing real-time feedback and insights. This has enabled companies to respond quickly and reap significant benefits from this convergence. An effective alternate method for measuring particle size that is precise, dependable, and efficient can be provided using AI-based particle analyzer […] The post 5 Advantages Of AI Particle Analyser Technology appeared first on Medical News Bulletin . ...

>Read More

Medical News Bulletin - Good news for men living with an enlarged prostate: clinicians have developed a novel way to treat Benign Prostate Hyperplasia (BPH) withoutsacrificing sexual function. On June 30, 2023, the FDA announced its approval of Optilume BPH for the treatment of an enlarged prostate. The next-generation Optilume BPH Catheter System offers a safe and effective new, […] The post Benign Prostate Hyperplasia: New Device Preserves Sexual Function appeared first on Medical News Bulletin . ...

>Read More

Medical News Bulletin - Post-viral syndrome is a spectrum of symptoms that stay on after infection with a virus. It can affect various body systems such as the nervous, musculoskeletal, and even the respiratory system. Sometimes, people suffer psychological symptoms. Post-viral syndrome can last for a few weeks to months or years and its severity varies among different people. […] The post What is Post-Viral Syndrome appeared first on Medical News Bulletin . ...

>Read More

Medical News Bulletin - The U.S. Food and Drug Administration (FDA) has expanded approval of QULIPTA® (atogepant) for use in preventative treatment of chronic migraine.1 In a press release from manufacturer AbbVie, Chief Medical Officer, Roopal Thakkar, explains, Since September 2021, QULIPTA has helped people living with episodic migraine prevent migraine attacks, reducing the daily burden of migraine. Now, […] The post FDA Approves Preventative Pill for Chronic Migraine appeared first on Medical News Bulletin . ...

>Read More

Product Details for 44029-233254